Denise Scots-Knight's Net Worth
$15.3 Million
Who is Denise Scots-Knight?
Denise Scots-Knight has an estimated net worth of $15.3 Million. This is based on reported shares across multiple companies, which include Mereo BioPharma Group plc, VIACELL INC, Elanco Animal Health Inc, ALBIREO PHARMA, INC., OncoMed Pharmaceuticals Inc, and IDENIX PHARMACEUTICALS INC.
SEC CIK
Denise Scots-Knight's CIK is 0001297000
Past Insider Trading and Trends
2005 was Denise Scots-Knight's most active year for acquiring shares with 2 total transactions. Denise Scots-Knight's most active month to acquire stocks was the month of May. 2014 was Denise Scots-Knight's most active year for disposing of shares, totalling 9 transactions. Denise Scots-Knight's most active month to dispose stocks was the month of July. 2005 saw Denise Scots-Knight paying a total of $0.00 for 1,702,184 shares, this is the most they've acquired in one year. In 2005 Denise Scots-Knight cashed out on 2,321,682 shares for a total of $12,973,953.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mereo BioPharma Group plc (MREO) Snapshot price: $4.03
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.78% | -132.99K |
$3.49 | -$463,486.80 | 709.52K |
Jun 25 - Jun 26
| |||
Form 4
| +50.34% | 282.09K |
—
|
—
| 842.5K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIACELL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 1.69M |
—
|
—
| 1.69M |
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elanco Animal Health Inc (ELAN) Snapshot price: $16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.12% | 20.37K |
—
|
—
| 60.23K |
Nov 30
| |||
Form 4
| +87.93% | 18.65K |
—
|
—
| 39.86K |
Nov 30
| |||
Form 4
| +52.56% | 7.31K |
—
|
—
| 21.21K |
Nov 30
| |||
Form 4
| +73.42% | 5.88K |
—
|
—
| 13.9K |
Nov 30
| |||
Form 4
| +188.03% | 5.23K |
—
|
—
| 8.02K |
Nov 29
| |||
Form 4
|
∞
| 2.78K |
—
|
—
| 2.78K |
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBIREO PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
∞
| 1.17M |
—
|
—
| 1.17M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||